HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Plans ACT, Gold Bond, Icy Hot Line Extensions In 2009

This article was originally published in The Tan Sheet

Executive Summary

In 2009, Chattem will launch the "first legitimate line extension" for ACT mouthwashes since it acquired the brand, according to President and Chief Operating Officer Bob Bosworth

You may also be interested in...



Chattem Builds Loyalty With Ad Spend, Outlines Strategies In Weak Economy

Chattem is investing more in advertising to build consumer loyalty and keep sales afloat during turbulent economic times as many financially-strapped shoppers turn to less expensive private label products

Recall Costs Trip Chattem As It Navigates Economic Downturn, Lawsuits

Chattem is making moves to overcome slumping consumer confidence and rising operating costs, but losses from a voluntary product recall kept its revenue growth relatively flat in the firm's most recent quarter

Chattem Hopes Brands Acquired From J&J Offset Cool Sales Of Pro-Therapy

For 2007, Chattem expects sales of products recently acquired from Johnson & Johnson to rival its existing "big three," of Gold Bond skin care, Icy Hot topical analgesics and Selsun medicated shampoos

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel